Emerging ethics principles could provide a starting point for medical device manufacturers grappling with potential concerns about AI.

Researchers from Queen Mary University found that the more fat found around the heart, the greater the diabetes risk.

The biggest medtech news of the week, in one minute or less.

The CE mark comes on the heels of Viz.ai raising $71 million in a series C round.

We need to adopt collaborative development strategies to collect real-world data and then use it as feedback to avoid racial bias in our medical device technologies.

New York-based Cleerly has raised $43 million in a series B round and brought in $54 million to date. Cleerly is also one of a growing number of companies at the intersection of artificial intelligence and the cardiovascular sector.

The acquisition continues the trend of upward mobility CareDx has experienced in recent months.

The San Francisco, CA-based company has won FDA clearance for a new design and upgraded artificial intelligence for the wearable cardiac monitor.

AliveCor said in its claim that it wants to block the importation of all the Apple Watches in U.S. – and said the tech giant is infringing on three counts of ECG patents.

The launch of the MCT platform puts VitalConnect in a league of its own.